WWP1 and cardiac hypertrophy: Recent studies have reported that WWP1 is involved in cardiac hypertrophy 20, atrial fibrosis 34, arrhythmogenesis 11 and heart failure (HF) with a preserved ejection fraction (EF; HFpEF) 12; however, these are non-ischemic cardiovascular diseases.